Advertisement

Internal and Emergency Medicine

, Volume 8, Issue 6, pp 543–545 | Cite as

Prothrombotic burden in a patient with recurrent thrombotic events: might an early assessment of thrombophilia be useful in the presence of a strong family history for vascular events?

  • Emanuele Cecchi
  • Rossella MarcucciEmail author
  • Elisa Ganugi
  • Rosanna Abbate
  • Cristina Giglioli
CE - LETTER TO THE EDITOR
  • 86 Downloads

Dear Editor,

A 55-year-old man (A. Z.) was admitted to Our Cardiac Step Down Unit of the tertiary center: Careggi Hospital, for an evaluation in the presence of a history of recurrent cardiovascular events.

Classical cardiovascular risk factors:

Hypertension on therapy with a good control, type 2 diabetes mellitus on metformin (3 g/day) with good glycemic control (glycated hemoglobin 5.6 %), high LDL cholesterol levels on statin treatment (rosuvastatin 20 mg/day) reaching a target of LDL 42 mg/dl; low HDL levels (24 mg/dl) on treatment, overweight (BMI 27.6). With regard to family history, almost all his relatives had suffered from a cardiovascular event (Fig.  1) at a young age.

Keywords

Clopidogrel Left Anterior Descend Rosuvastatin Right Coronary Artery Thrombotic Event 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Conflict of interest

None.

References

  1. 1.
    Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, Mackie I, Makris M, Nokes T, Perry D, Tait RC, Walker I, Watson H, British Committee for Standards in Haematology (2010) Clinical guidelines for testing for heritable thrombophilia. Br J Haematol 149:209–220PubMedCrossRefGoogle Scholar
  2. 2.
    Middeldorp S, van HylckamaVlieg A (2008) Does thrombophilia testing help in the clinical management of patients? Br J Haematol 143:321–335PubMedCrossRefGoogle Scholar
  3. 3.
    Vossen CY, Rosendaal FR, EPCOT Study Group (2006) Risk of arterial thrombosis in carriers of familial thrombophilia. J Thromb Haemost 4:916–918PubMedCrossRefGoogle Scholar
  4. 4.
    Inbal A, Freimark D, Modan B, Chetrit A, Matetzky S, Rosenberg N, Dardik R, Baron Z, Seligsohn U (1999) Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males. Blood 93:2186–2190PubMedGoogle Scholar
  5. 5.
    Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF, Ginsberg H, Amarenco P, Catapano A, Descamps OS, Fisher E, Kovanen PT, Kuivenhoven JA, Lesnik P, Masana L, Reiner Z, Taskinen MR, Tokgözoglu L, Tybjærg-Hansen A, European Atherosclerosis Society Consensus Panel (2010) Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J 31:2844–2853PubMedCrossRefGoogle Scholar

Copyright information

© SIMI 2013

Authors and Affiliations

  • Emanuele Cecchi
    • 1
  • Rossella Marcucci
    • 2
    Email author
  • Elisa Ganugi
    • 2
  • Rosanna Abbate
    • 2
  • Cristina Giglioli
    • 1
  1. 1.Department of Heart and VesselsAzienda Ospedaliero-Universitaria CareggiFlorenceItaly
  2. 2.Department of Medical and Surgical Critical CareUniversity of FlorenceFlorenceItaly

Personalised recommendations